Beneficial Ownership Report · SCHEDULE 13D/A
Bolt Biotherapeutics, Inc.
BOLTNASDAQEQUITYCurrent
Beneficial Ownership Report
Structured filing — SCHEDULE 13D/A
primary_doc.xml
Amendment · This filing reports the amendment as submitted.
Subject company
- Company
- Bolt Biotherapeutics, Inc.
- Company CIK
- 0001641281
- Street
- 900 Chesapeake Drive
- City
- Redwood City
- State / country code
- CA
- Postal code
- 94063
Statement details
- Amendment number
- 4
- Security class
- Common Stock, $0.00001 par value
- Event date
- 02/24/2026
- Previously filed indication
- false
Authorized notification person 1
- Name
- Robert Hopfner
- Phone
- (415) 697-1002
- Street
- Pivotal bioVenture Partners Fund I UGP
- Street (continued)
- 501 2nd Street, Suite 200
- City
- San Francisco
- State / country code
- CA
- Postal code
- 94107
Authorized notification person 2
- Name
- Louis Rambo
- Phone
- (202) 416-6800
- Street
- Proskauer Rose, LLP
- Street (continued)
- 1001 Pennsylvania Avenue NW, Suite 600
- City
- Washington
- State / country code
- DC
- Postal code
- 20004-2533
Reporting person 1
- Name
- Nan Fung Group Holdings Limited
- Reporting person CIK
- 0001782539
- No reporting person CIK indication
- N
- Citizenship / organization
- D8
- Reporting person type
- CO
- Group designation
- b
- Source of funds code
- AF
- Legal proceedings indication
- N
- Aggregate amount owned
- 87,486
- Percent of class
- 4.6
- Sole voting power
- 0
- Shared voting power
- 87,486
- Sole dispositive power
- 0
- Shared dispositive power
- 87,486
- Aggregate excludes certain shares
- N
Reporting person 2
- Name
- NF Investment Holdings Limited
- No reporting person CIK indication
- Y
- Citizenship / organization
- D8
- Reporting person type
- CO
- Group designation
- b
- Source of funds code
- AF
- Legal proceedings indication
- N
- Aggregate amount owned
- 87,486
- Percent of class
- 4.6
- Sole voting power
- 0
- Shared voting power
- 87,486
- Sole dispositive power
- 0
- Shared dispositive power
- 87,486
- Aggregate excludes certain shares
- N
Reporting person 3
- Name
- Pivotal bioVenture Partners Fund I, L.P.
- Reporting person CIK
- 0001695076
- No reporting person CIK indication
- N
- Citizenship / organization
- E9
- Reporting person type
- PN
- Group designation
- b
- Source of funds code
- WC
- Legal proceedings indication
- N
- Aggregate amount owned
- 52,556
- Percent of class
- 2.7
- Sole voting power
- 0
- Shared voting power
- 52,556
- Sole dispositive power
- 0
- Shared dispositive power
- 52,556
- Aggregate excludes certain shares
- N
Reporting person 4
- Name
- Pivotal bioVenture Partners Fund I G.P., L.P.
- Reporting person CIK
- 0001752862
- No reporting person CIK indication
- N
- Citizenship / organization
- E9
- Reporting person type
- PN
- Group designation
- b
- Source of funds code
- AF
- Legal proceedings indication
- N
- Aggregate amount owned
- 52,556
- Percent of class
- 2.7
- Sole voting power
- 0
- Shared voting power
- 52,556
- Sole dispositive power
- 0
- Shared dispositive power
- 52,556
- Aggregate excludes certain shares
- N
Reporting person 5
- Name
- Pivotal bioVenture Partners Fund I U.G.P. Ltd.
- No reporting person CIK indication
- Y
- Citizenship / organization
- E9
- Reporting person type
- CO
- Group designation
- b
- Source of funds code
- AF
- Legal proceedings indication
- N
- Aggregate amount owned
- 52,556
- Percent of class
- 2.7
- Sole voting power
- 0
- Shared voting power
- 52,556
- Sole dispositive power
- 0
- Shared dispositive power
- 52,556
- Aggregate excludes certain shares
- N
Reporting person 6
- Name
- Pivotal Partners Ltd
- No reporting person CIK indication
- Y
- Citizenship / organization
- E9
- Reporting person type
- CO
- Group designation
- b
- Source of funds code
- AF
- Legal proceedings indication
- N
- Aggregate amount owned
- 52,556
- Percent of class
- 2.7
- Sole voting power
- 0
- Shared voting power
- 52,556
- Sole dispositive power
- 0
- Shared dispositive power
- 52,556
- Aggregate excludes certain shares
- N
Reporting person 7
- Name
- Pivotal Life Sciences Holdings Limited
- No reporting person CIK indication
- Y
- Citizenship / organization
- E9
- Reporting person type
- CO
- Group designation
- b
- Source of funds code
- AF
- Legal proceedings indication
- N
- Aggregate amount owned
- 52,556
- Percent of class
- 2.7
- Sole voting power
- 0
- Shared voting power
- 52,556
- Sole dispositive power
- 0
- Shared dispositive power
- 52,556
- Aggregate excludes certain shares
- N
Reporting person 8
- Name
- Nan Fung Life Sciences Holdings Limited
- No reporting person CIK indication
- Y
- Citizenship / organization
- D8
- Reporting person type
- CO
- Group designation
- b
- Source of funds code
- AF
- Legal proceedings indication
- N
- Aggregate amount owned
- 82,486
- Percent of class
- 4.3
- Sole voting power
- 0
- Shared voting power
- 82,486
- Sole dispositive power
- 0
- Shared dispositive power
- 82,486
- Aggregate excludes certain shares
- N
Reporting person 9
- Name
- Permwell Management Limited
- No reporting person CIK indication
- Y
- Citizenship / organization
- E9
- Reporting person type
- CO
- Group designation
- b
- Source of funds code
- WC
- Legal proceedings indication
- N
- Aggregate amount owned
- 5,000
- Percent of class
- 0.3
- Sole voting power
- 0
- Shared voting power
- 5,000
- Sole dispositive power
- 0
- Shared dispositive power
- 5,000
- Aggregate excludes certain shares
- N
Reporting person 10
- Name
- NFLS Beta Limited
- No reporting person CIK indication
- Y
- Citizenship / organization
- D8
- Reporting person type
- CO
- Group designation
- b
- Source of funds code
- WC
- Legal proceedings indication
- N
- Aggregate amount owned
- 29,930
- Percent of class
- 1.6
- Sole voting power
- 0
- Shared voting power
- 29,930
- Sole dispositive power
- 0
- Shared dispositive power
- 29,930
- Aggregate excludes certain shares
- N
Reporting person 11
- Name
- NFLS Platform Holdings Limited
- No reporting person CIK indication
- Y
- Citizenship / organization
- E9
- Reporting person type
- CO
- Group designation
- b
- Source of funds code
- WC
- Legal proceedings indication
- N
- Aggregate amount owned
- 29,930
- Percent of class
- 1.6
- Sole voting power
- 0
- Shared voting power
- 29,930
- Sole dispositive power
- 0
- Shared dispositive power
- 29,930
- Aggregate excludes certain shares
- N
Item 1
Issuer
Bolt Biotherapeutics, Inc.
Security title
Common Stock, $0.00001 par value
Principal address
Item 5
Number of shares
The information set forth in rows 7 through 10 of the cover pages to this Schedule 13D is incorporated by reference.
Transactions
Except as set forth on Schedule A, which is incorporated into this Item 5(c) by reference, no Reporting Person has effected any transaction in shares of Common Stock in the past sixty days.
Date ownership ceased to exceed 5%
On February 26, 2026, the Reporting Persons ceased to be the beneficial owners of more than five percent of the Common Stock.
Percentage of class
Items 5(a)-(c) and Item 5(e) of the Schedule 13D are amended and restated as follows: The information set forth in rows 11 and 13 of the cover pages to this Schedule 13D is incorporated by reference. The percentages set forth in row 13 are based on 1,919,441 outstanding shares of Common Stock, as reported by the Issuer in its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 12, 2025. In addition, Mr. Kam Chung Leung directly owns 8,684 shares of Common Stock.
Signature 1
- Reporting person
- Nan Fung Group Holdings Limited
- Signed
- /s/ Tang Chun Wai Nelson
- Title
- Tang Chun Wai Nelson, Director
- Date
- 02/26/2026
Signature 2
- Reporting person
- NF Investment Holdings Limited
- Signed
- /s/ Tang Chun Wai Nelson
- Title
- Tang Chun Wai Nelson, Director
- Date
- 02/26/2026
Signature 3
- Reporting person
- Pivotal bioVenture Partners Fund I, L.P.
- Signed
- By Pivotal bioVenture Partners Fund I G.P., L.P. · By Pivotal bioVenture Partners Fund I U.G.P., Ltd. · /s/ Robert Hopfner
- Title
- its General Partner · its General Partner · Robert Hopfner, Authorized Signatory
- Date
- 02/26/2026 · 02/26/2026 · 02/26/2026
Signature 4
- Reporting person
- Pivotal bioVenture Partners Fund I G.P., L.P.
- Signed
- By Pivotal bioVenture Partners Fund I U.G.P., Ltd. · /s/ Robert Hopfner
- Title
- its General Partner · Robert Hopfner, Authorized Signatory
- Date
- 02/26/2026 · 02/26/2026
Signature 5
- Reporting person
- Pivotal bioVenture Partners Fund I U.G.P. Ltd.
- Signed
- /s/ Robert Hopfner
- Title
- Robert Hopfner, Authorized Signatory
- Date
- 02/26/2026
Signature 6
- Reporting person
- Pivotal Partners Ltd
- Signed
- /s/ Sun Xintong
- Title
- Sun Xintong, Director
- Date
- 02/26/2026
Signature 7
- Reporting person
- Pivotal Life Sciences Holdings Limited
- Signed
- /s/ Sun Xintong
- Title
- Sun Xintong, Director
- Date
- 02/26/2026
Signature 8
- Reporting person
- Nan Fung Life Sciences Holdings Limited
- Signed
- /s/ Sun Xintong
- Title
- Sun Xintong, Director
- Date
- 02/26/2026
Signature 9
- Reporting person
- Permwell Management Limited
- Signed
- /s/ Tang Chun Wai Nelson
- Title
- Tang Chun Wai Nelson, Director
- Date
- 02/26/2026
Signature 10
- Reporting person
- NFLS Beta Limited
- Signed
- /s/ Sun Xintong
- Title
- Sun Xintong, Director
- Date
- 02/26/2026
Signature 11
- Reporting person
- NFLS Platform Holdings Limited
- Signed
- /s/ Sun Xintong
- Title
- Sun Xintong, Director
- Date
- 02/26/2026
Filed exhibits
- EX-99.A ↗ormp-ex99_a.htm
Company context
Bolt Biotherapeutics is a clinical-stage biotechnology company pioneering a new generation of half-life-extended multispecific antibodies designed to deliver best-in-disease therapies. Through the proprietary INSPIRE platform it acquired from Prana Therapies, the company combines complementary therapeutic mechanisms in fully IgG-based molecules designed for differentiated efficacy, extended exposure, and convenient dosing.